Abstract
Progestin and AdipoQ Receptor 3 (PAQR3), a member of the PAQR family, is down-regulated in several types of cancers and has been closely associated with tumor progression and development. However, little is known about the functions of PAQR3 in the tumorigenesis of human glioma. Therefore, in this report, we investigated the role of PAQR3 in human glioma. Our results showed that the expression of PAQR3 was significantly reduced in human glioma tissues and cell lines. PAQR3 overexpression inhibited the proliferation of glioma cells in vitro and attenuated tumor xenograft growth in vivo. In addition, PAQR3 overexpression suppressed the migration and invasion of glioma cells, as well as prevented the EMT process. Mechanistic studies demonstrated that PAQR3 overexpression significantly down-regulated the levels of phosphorylated PI3K and Akt in U251 cells. In conclusion, these results demonstrated that PAQR3 inhibited the proliferation, migration and invasion in glioma cells, at least in part, through the inactivation of PI3K/Akt signaling pathway. Therefore, PAQR3 may be a therapeutic target for the treatment of glioma.
References
May 12, 2004·Nature Reviews. Drug Discovery·Jeremy N Rich, Darell D Bigner
Jul 27, 2005·Journal of Molecular Evolution·Y Tom TangWalter D Funk
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jan 27, 2009·Cancer Metastasis Reviews·Mahmut Yilmaz, Gerhard Christofori
Nov 4, 2009·Molecular and Cellular Biology·Yuhui JiangYan Chen
Oct 5, 2010·Brain Research·Lei HanChunsheng Kang
Nov 10, 2010·Neurology·Lynne P Taylor
Apr 8, 2011·Expert Review of Neurotherapeutics·Tobias Walbert, Tom Mikkelsen
Jul 26, 2012·Carcinogenesis·Xiao WangYan Chen
Oct 23, 2012·Diabetes·Xiao WangYan Chen
Sep 17, 2013·Endocrinology·Lingdi WangYan Chen
Oct 12, 2013·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Yong-Rong YanXue-Yun Zhong
Oct 14, 2014·Oncology Reports·Hong Ge WuPin Dong Li
Oct 21, 2014·PloS One·Youcheng XiuQiong Wu
Dec 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhiqiang MaJianyu Liu
Aug 28, 2015·Nature Communications·Daqian XuYan Chen
Sep 10, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yan JiangChang Liu
Jan 2, 2016·Oncology Letters·Wei DUXinting Wei
Feb 3, 2016·The EMBO Journal·Da-Qian XuYan Chen
Feb 26, 2016·Carcinogenesis·Weiwei GuoYan Chen
Mar 12, 2016·Oncotarget·Xiaoman LiLiang Wang
Mar 22, 2016·Oncology Letters·Yasuo Iwadate
Jul 18, 2016·Journal of the Neurological Sciences·Guo-Zhong YiSong-Tao Qi
Jul 28, 2016·Oncology Reports·Jinpeng ChenZhiwei Wang
Sep 15, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ming TuWeiming Zheng
Jul 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Z Q LingY Chen
Citations
Nov 30, 2020·Life Sciences·Shanshan QiaoWenlan Liu
May 7, 2021·Immunity, Inflammation and Disease·Ling Jin, Laigen Tong
Oct 1, 2021·Cell Death & Disease·Chunyu ZhangShuzhong Yao
Dec 19, 2021·Environmental Toxicology·So Yeon YuSeung Yong Hwang